Chief Medical Officer, Dr. Jacqueline Bisasor McKenzie, says the anti-malarial drug, hydroxychloroquine, will not be used to treat COVID-19 patients in Jamaica. 

Dr. Bisasor McKenzie says this decision was taken by the health ministry following recommendations from experts across the island who are reviewing treatment methods being tried internationally.

She says the World Health Organization, WHO, is in support of Jamaica’s move to not include hydroxychloroquine as part of the treatment protocol. 

In the past few weeks, hydroxychloroquine has been the subject of raging debates after being touted as an effective remedy against COVID-19.

Dr Bisasor Mckenzie says Jamaica is aware of the ongoing studies on the use of the drug in treating patients. 

The CMO says there are specific treatment and monitoring guidelines that need to be strictly observed when using the drug.